In regards to Roach et al. defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference (Int J Radiat Oncol Biol Phys 2006;65:965-974)

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 4, 2006, Pages 1274-

  Cheung, Rex ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; DOSIMETRY; HORMONAL THERAPY; HUMAN; LETTER; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION RESPONSE; TREATMENT FAILURE;

ANDROGEN ANTAGONISTS; COMBINED MODALITY THERAPY; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL; TREATMENT FAILURE;

EID: 33750328855     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.07.010     Document Type: Letter

References (6)

1. Roach M., Hanks G., Thames H.J., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
2. Thames H., Kuban D., Levy L., et al. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. Int J Radiat Oncol Biol Phys 57 (2003) 929-943
3. Cheung R., Tucker S.L., Lee A.K., et al. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 993-1002
4. Cheung R., Tucker S.L., Lee A.L., et al. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 14-19
5. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
6. Bentzen S.M., and Ritter M.A. The alpha/beta ratio for prostate cancer: what is it, really?. Radiother Oncol 76 (2005) 1-3